O2.2 Ninety-day mortality following TORS or definitive radiotherapy for oropharyngeal cancer at American commission on cancer-accredited facilities. (November 2022) - Janopaul-Naylor, J.; Rupji, M.; Switchenko, J.; Stokes, W.; Patel, M.; Bates, J.